11.12.2012 Views

NASA Scientific and Technical Aerospace Reports

NASA Scientific and Technical Aerospace Reports

NASA Scientific and Technical Aerospace Reports

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Metastasis-suppressor genes suppress the growth of metastases without affecting tumor growth. We have been studying<br />

the role of inactivation of one such metastasis suppressor gene, Map Kinase 4 (MKK4) in the process of metastatic<br />

colonization. Work proposed in this application is aimed at extending our ongoing studies in the AT6.1 model system into new<br />

transgenic models of prostate cancer. In the past year we have made significant progress in the immunohistochemical studies<br />

proposed in the initial application <strong>and</strong> the development of gene targeting vectors for animal studies.<br />

DTIC<br />

Cancer; Genes; Metastasis; Prostate Gl<strong>and</strong>; Suppressors<br />

20040111752 Henry Ford Health System, Detroit, MI<br />

Hormone Receptors in Breast Cancer Prognosis - Racial <strong>and</strong> Quantitative Effects<br />

Tammemagi, Carl M.; Jun. 2003; 56 pp.; In English<br />

Contract(s)/Grant(s): DAMD17-00-1-0287<br />

Report No.(s): AD-A425960; No Copyright; Avail: CASI; A04, Hardcopy<br />

Breast cancer survivors compose the largest group of cancer survivors in the USA. As heterogeneity exists within stages<br />

<strong>and</strong> between races in breast cancer survival, it is important to develop a better underst<strong>and</strong>ing of prognostic factors. Tumor<br />

estrogen <strong>and</strong> progesterone receptors are one of the more important prognostic factors in breast cancer patients. However,<br />

currently in clinical practice hormone receptor status is treated as either being present or absent <strong>and</strong> is treated similarly in all<br />

groups. The dichotomization of hormone status may lead to loss of valuable information <strong>and</strong> hormone receptor status may not<br />

have the same effect in African Americans <strong>and</strong> Whites. This historical cohort study evaluates quantitative differences in tumor<br />

hormone receptors in African Americans <strong>and</strong> Whites <strong>and</strong> determines whether survival effects differ between the two groups.<br />

This study also assesses whether a dose-response relationship, linear or nonlinear, exists between hormone receptors <strong>and</strong><br />

survival. Findings of this study may lead to better prediction of survival <strong>and</strong> to identification of subsets of patients at higher<br />

risk that may have gone unrecognized by the application of a single cutpoint. Our preliminary findings indicate that African<br />

American breast cancer patients have more estrogen receptor negativity <strong>and</strong> a worse survival.<br />

DTIC<br />

Cancer; Hormones; Mammary Gl<strong>and</strong>s; Prognosis<br />

20040111753 National Jewish Medical <strong>and</strong> Research Center, Denver, CO<br />

Cloning <strong>and</strong> Characterization of Genes That Inhibit TRAIL-Induced Apoptosis of Breast Cancer Cells<br />

Shu, Hong-Bing; Apr. 2004; 13 pp.; In English<br />

Contract(s)/Grant(s): DAMD17-00-1-0358<br />

Report No.(s): AD-A425962; No Copyright; Avail: CASI; A03, Hardcopy<br />

TRAIL is a tumor necrosis factor family member that can specifically induce apoptosis of cancer cells but not of normal<br />

cells. However, some cancer cells are resistant to TRAIL-induced apoptosis. The purpose of this proposed study is to clone<br />

<strong>and</strong> characterize such inhibitory genes of TRAIL- induced apoptosis. Using cDNA subtraction <strong>and</strong> retroviral cDNA- based<br />

expression cloning approaches, we have obtained more than multiple c<strong>and</strong>idate clones of TRAIL-inhibitory genes. Among the<br />

c<strong>and</strong>idate clones, the short splice form of Casper/c- FLIP (Casper-S were shown to confer resistance to TRAIL- induced<br />

apoptosis. Casper deficient embryonic cells were sensitive to TRAIL-induced apoptosis. Re- introduction of Casper-S into<br />

Casper deficient cells conferred resistance to TRAIL-induced apoptosis. This project has identified <strong>and</strong> validated Casper-S as<br />

a major cellular inhibitor of TRAIL- induced apoptosis.<br />

DTIC<br />

Apoptosis; Cancer; Cloning (Biology); Genes; Mammary Gl<strong>and</strong>s<br />

20040111755 V<strong>and</strong>erbilt Univ., Nashville, TN<br />

Regulation of ErbB-2 Metabolic Stability<br />

Carpenter, Graham F.; Mar. 2004; 43 pp.; In English<br />

Contract(s)/Grant(s): DAMD17-00-1-0483<br />

Report No.(s): AD-A425964; No Copyright; Avail: CASI; A03, Hardcopy<br />

This grant has focused on the mechanism by which geldanamycin controls the metabolic stability of ErbB-2, a coreceptor<br />

tyrosine kinase. ErbB-2 is overexpressed in breast cancer <strong>and</strong> is known to increase cell proliferation. Geldanamycin<br />

decreases ErbB-2 levels in cells <strong>and</strong> is in clinical trials for the treatment of breast cancer. Our studies in this grant have<br />

examined the mechanism by which geldanamycin decreases ErbB-2 levels. Published data demonstrate that geldanamycin<br />

provokes prpteolytic cleavage events within the ErbB-2 intracellular domain <strong>and</strong> thereby decreases the level of the mature<br />

221

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!